EBEsmaeel Babaeenezhad

Esmaeel Babaeenezhad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Esmaeel Babaeenezhad has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Antioxidative and anti-inflammatory effects of monoterpene linalool in rats with letrozole-induced polycystic ovarian syndrome: modulation of autophagy and apoptosis

    by Donya Farzane Yegane, Seifollah Bahramikia, Esmaeel Babaeenezhad, Omid Dezfoulian

    Polycystic ovarian syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting women of reproductive age, frequently associated with infertility, metabolic complications, and chronic inflammation mediated by NF-κB activation. This is the first study to examine the effects of linalool (Lin), an acyclic monoterpene, on PCOS-related complications in rats. Adult female rats were randomly assigned to six experimental groups (n = 6): control, Lin 100, PCOS, PCOS + Lin 50, PCOS + Lin 100, and PCOS + Metformin (Met). To induce PCOS, letrozole (1 mg/kg) was administered orally to the rats for 21 days. After PCOS induction, the rats were orally treated with Lin (50 and 100 mg/kg) and Met (300 mg/kg) for 14 days. Linalool remarkably mitigated ovarian histopathological alterations and fibrosis and significantly improved fasting blood glucose levels and insulin sensitivity in PCOS rats. Hormonal disturbances in PCOS rats, including elevated LH and testosterone levels, decreased FSH levels, and increased LH/FSH ratio, were considerably ameliorated after Lin treatment. Additionally, Lin treatment markedly decreased oxidative stress and inflammatory responses in PCOS rats, as demonstrated by enhanced glutathione peroxidase activity and decreased malondialdehyde, NF-κB p65, and TNF-α levels. Linalool partially restored impaired autophagy in PCOS rats by upregulating LC3-I and LC3-II. Conversely, Lin administration significantly inhibited excessive ovarian apoptosis in PCOS rats through downregulating cleaved caspase-3 and reducing the cleaved caspase-3/procaspase-3 ratio. In summary, Lin improved PCOS-induced ovarian and metabolic abnormalities in rats by regulating oxidative stress, inflammation, autophagy, and apoptosis, highlighting its potential for PCOS management.


  • Open Access

    Quercetin pretreatment improves hepatorenal dysfunction and lipid profile abnormalities by reducing oxidative stress in rats subjected to renal ischemia-reperfusion injury

    by Mohsen Mehrjoo, Seifollah Bahramikia, Mehran Ghadami, Sahar Yarahmadi, Hassan Ahmadvand, Esmaeel Babaeenezhad

    Introduction: Quercetin, a polyphenolic compound, exhibits potent antioxidant and anti-inflammatory activities in oxidative stress conditions. Objectives: This study aimed to determine whether quercetin pretreatment could alleviate oxidative stress and hepatorenal dysfunction in rats exposed to renal ischemia-reperfusion (IR) injury. Materials and Methods: This experimental study employed an animal model with a post-test-only control group design. Thirty male Sprague–Dawley rats were randomly allocated into three groups (n = 10): control (vehicle); IR, which received the vehicle and underwent IR; and quercetin-pretreated group (IR + Quercetin), which was pretreated with quercetin (50 mg/kg/day) prior to IR induction. The rats were orally pretreated with either vehicle or quercetin for 15 consecutive days prior to IR exposure. To induce kidney ischemia, both kidney pedicles were compressed using atraumatic clamps (45 min), and reperfusion (24 h) was initiated by removing the clamps. Results: Serum levels of triglycerides, cholesterol, low-density lipoprotein, very low-density lipoprotein, urea, and creatinine, as well as the activities of gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), and alanine aminotransferase (ALT), were markedly reduced in the IR + Quercetin group compared to the IR group. The concentration of high-density lipoprotein cholesterol was significantly increased in the IR + Quercetin group compared to the IR group. In rats exposed to IR, quercetin pretreatment significantly decreased malondialdehyde concentrations and promoted glutathione contents as well as catalase and glutathione peroxidase activities in serum, renal, and hepatic samples compared to the IR group. Conclusion: Quercetin pretreatment exerted protective effects against hepatorenal dysfunction and oxidative stress in rats subjected to kidney IR injury.

  • Open Access

    Betaine Mitigates Paclitaxel‐Induced Hepatotoxicity in Rats by Regulating Oxidative Stress, Inflammation, Apoptosis, and Autophagy

    by Esmaeel Babaeenezhad, Niloofar Moammer, Marjan Joudaki, Omid Dezfoulian, Sahar Yarahmadi, Seifollah Bahramikia

    Paclitaxel (PTL) is widely used in chemotherapy; however, its efficacy is compromised by the risk of liver toxicity. This is the first study to investigate the protective effect of betaine (BTN) against PTL‐induced liver injury. Rats were randomly divided into five experimental groups ( n = 7 per group): control (saline), BTN (100 mg/kg/day), PTL (2 mg/kg/day), PTL + BTN (2 and 50 mg/kg/day), and PTL + BTN (2 and 100 mg/kg/day). After the rats received 2 mg/kg body weight PTL intraperitoneally for the first five consecutive days, BTN was administered orally for 10 days. Our results indicate that BTN restores liver antioxidant levels (SOD, FRAP, and GSH), improves liver function by lowering AST and ALT levels, and attenuates PTL‐induced lipid peroxidation. In the livers of PTL‐treated rats, BTN significantly decreased the levels of NF‐κB and TNF‐α proteins and the ratio of caspase‐3/pro‐caspase‐3, whereas it increased the levels of Nrf2, LC3‐II/LC3‐I, and Bcl‐2. In summary, the results of this study suggest that BTN may ameliorate PTL‐induced liver injury by regulating oxidative stress, inflammation, apoptosis, and autophagy.

  • Implications of miRNA-590 dysregulation in digestive tract malignancies: mechanistic aspects and clinical significance

    by Sahar Yarahmadi, Mostafa Moradi Sarabi, Zohreh Abdolvahabi, Seyedeh Sara Ghorbanhosseini, Esmaeel Babaeenezhad

    Digestive tract cancers are a common health concern worldwide. In recent years, dysregulation of miRNA-590 in digestive tract malignancies has been extensively studied. Alterations in its expression are related to clinical outcomes, such as tumor grade, patient prognosis, metastasis, recurrence, response to adjuvant therapy, and overall survival. Therefore, miRNA-590 has the potential to serve as a candidate prognostic and diagnostic biomarker, as well as a therapeutic target. In this study, we focus on the role of miRNA-590 in the biology of digestive tract cancers. It has been shown that miRNA-590 can act as either a tumor suppressor or an oncogene depending on the tumor type, affecting growth, invasion, angiogenesis, and resistance to chemotherapeutic agents. Additionally, we specifically discuss the downstream effects of miRNA-590 and its upstream regulators, as well as its potential as a diagnostic and prognostic marker and promising target for cancer therapy.


  • Open Access

    Resveratrol Relieves Hepatic Steatosis and Enhances the Effects of Atorvastatin in a Mouse Model of NAFLD by Regulating the Renin‐Angiotensin System, Oxidative Stress, and Inflammation

    by Esmaeel Babaeenezhad, Navid Farahmandian, Mohammadjavad Sotoudeheian, Omid Dezfoulian, Elaheh Askari, Niloofar Taghipour, Sahar Yarahmadi

    The classical renin‐angiotensin system (RAS) axis is implicated in NAFLD development by promoting oxidative stress and inflammation, whereas the nonclassical axis antagonizes its effects. In the present study, we evaluated the effects of resveratrol (RSV), a polyphenol antioxidant, alone and in combination with atorvastatin (AT) on the RAS axes in NAFLD mice. Male C57/BL6 mice were fed a normal diet (control group) or a high‐fat diet (HFD) for 12 weeks to induce NAFLD. Afterwards, the animals received AT (20 mg/kg), RSV (100 mg/kg/day), and AT + RSV (20 and 100 mg/kg/day) by oral gavage for 4 weeks. NAFLD animals exhibited swollen hepatocytes with numerous fat‐containing vacuoles. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were increased in NAFLD mice. Additionally, HFD mice exhibited dyslipidemia, as manifested by increased cholesterol (Chol), triglyceride (TG), and low‐density lipoprotein cholesterol (LDL‐C), and decreased high‐density lipoprotein cholesterol (HDL‐C). HFD significantly increased oxidative stress, as manifested by high levels of malondialdehyde and low paraoxonase 1 activity. Additionally, NAFLD mice showed significantly increased IL‐1β, IL‐6, and TNF‐α expression and reduced IL‐10 expression. An imbalance among RAS axes was evident as high expression levels of angiotensinogen, renin, and type 1 angiotensin receptor and reduced expression levels of angiotensin‐converting enzyme 2 and angiotensin 1–7. RSV ameliorated these changes in NAFLD mice, which were comparable with the beneficial effects of AT. Interestingly, the ameliorative effects of AT increased considerably when it was administered in combination with RSV. Overall, our findings indicate that RSV attenuates HFD‐induced NAFLD in mice, particularly when co‐administered with AT, at least by regulating the RAS axes, oxidative stress, and inflammation.


  • Open Access

    Antimicrobial activity and cytotoxic and epigenetic effects of tannic acid-loaded chitosan nanoparticles

    by Marzieh Rashidipour, Saber Abbaszadeh, Mehdi Birjandi, Naser Pajouhi, Shahram Ahmadi Somaghian, Gholamreza Goudarzi, Soroosh Shahryarhesami, Mostafa Moradi Sarabi, Esmaeel Babaeenezhad

    Tannic acid (TA) is a potent antitumor agent, but its low bioavailability and absorption limit its use. In this study, it was loaded into chitosan-based nanoparticles (Chi-NPs) to overcome these limitations and to improve its antimicrobial and anticancer activities. TA-loaded Chi-NPs (Chi-TA-NPs) were synthesized using the ionic gelation method and physicochemically characterized by FE-SEM, FTIR, XRD, PDI, DLS, and zeta potential analysis. Additionally, the antimicrobial activity of Chi-TA-NPs against two G+ bacterial strains, two G− bacterial strains, and a fungal strain (Candida albicans) was investigated using the microbroth dilution method. MTT assay was used to examine the cytotoxic effects of Chi-TA-NPs on HepG2 cells. The expression of DNA methyltransferase 1 (DNMT1), DNMT3A, and DNMT3B was examined in HepG2 cells using RT-qPCR. The amount of 5-methylcytosine in the HepG2 cell-derived genomic DNA was measured using ELISA. FE-SEM micrographs showed the loading of TA into the chitosan-based formulation. The peaks detected in the XRD and FTIR analyses confirmed the formation of the Chi-TA-NPs. The PDI value (0.247 ± 0.03), size (567.0 ± 25.84 nm), and zeta potential (17.0 ± 5.86 mV) confirmed the relative stability of Chi-TA-NPs. A constant release profile in line with the Korsmeyer-Peppas model was detected for Chi-TA-NPs, such that approximately 44% of TA was released after 300 min. In addition, Chi-TA-NPs exhibited effective antimicrobial activity against the studied microbial strains, as manifested by MIC values ranging from 250 to 1000 µg/mL. Chi-TA-NPs induced cytotoxicity in liver tumor cell line, with an IC50 value of 500 µg/mL. Furthermore, Chi-TA-NPs considerably decreased the expression of DNMT1 (2.52-fold; p = 0.01), DNMT3A (2.96-fold; p = 0.004), and DNMT3B (2.94-fold; p < 0.0001). However, 5-methylcytosine levels in HepG2 cells were unaffected by Chi-TA-NPs treatment (p = 0.62). Finally, the antimicrobial, cytotoxic, and epigenetic effects of Chi-TA-NPs were more pronounced than those of free TA and the unloaded Chi-NPs. In conclusion, Chi-TA-NPs exhibit promising potential for reducing microbial growth and promoting cytotoxicity in liver cancer cells.


  • Open Access

    The combination effects of sodium selenite and vitamin E on renal ischemia-reperfusion injury in rats

    by Sahar Yarahmadi, Mohsen Mehrjoo, Sahar Asgharzadeh, Samaneh Pakravan, Hassan Ahmadvand, Esmaeel Babaeenezhad

    Introduction: Renal ischemia-reperfusion (RIR) injury is one of the main causes of acute kidney failure. Objectives: The purpose of this study was to assess the effects of vitamin E, as well as a combination of vitamin E and sodium selenite (Se), on a rat model of RIR injury. Materials and Methods: Current study was a laboratory experimental investigation using a post-test only control group desgin. A total of thirty-two adult male Sprague Dawley rats were divided into four equal groups: group 1 (control), group 2 [(IR; ischemia-reperfusion) + 0.25 mL saline)], group 3 (IR+1 mg/kg sodium Se and 100 mg/kg vitamin E), and group 4 (IR+100 mg/kg vitamin E). RIR injury was initiated by clamping the right and left pedicles for a duration of 45 minutes, followed by a 24-hour period of reperfusion. The intraperitoneal administration of daily therapy commenced 12 days prior to the development of RIR. Results: Ischemia-reperfusion injury resulted in a considerable elevation in serum levels of urea, creatinine, and malondialdehyde (MDA), as well as enhanced serum myeloperoxidase (MPO) activity and renal MDA levels. Nevertheless, RIR markedly reduced the concentration of glutathione (GSH) in the serum, as well as the enzymatic activities of glutathione peroxidase (GPX) and paraoxonase 1 (PON1) in the serum. Additionally, RIR decreased the enzymatic activities of GPX and catalase (CAT) in the kidneys. In RIR animals, sodium Se plus vitamin E significantly improved renal function parameters, MDA content, GSH, and GPX activity in the kidneys. Conclusion: Our findings showed that the effects of sodium Se and vitamin E on reducing oxidative stress and inflammatory markers and improving renal function biomarkers were comparable to those of vitamin E alone.


  • Green synthesis of gold nanoparticles (AuNPs) using aqueous extract and essential oils from Satureja Khuzestanica Jamzad: evaluation of their antibacterial and antifungal activities

    by Marzieh Rashidipour, Setareh Soroush, Behnam Ashrafi, Asghar Sepahvand, Bahram Rasoulian, Seyed Sajad Sohrabi, Esmaeel Babaeenezhad


  • Global and Regional DNA methylation silencing of PPARγ Associated with Glioblastoma Multiforme Pathogenesis

    by Esmaeel Babaeenezhad, Mostafa Moradi Sarabi, Masoumeh Rajabibazl, Saeed Oraee-Yazdani, Saeed Karima

    Background The relationship between peroxisome proliferator-activated receptor gamma (PPARγ) expression level and epigenetic modifications occurring in glioblastoma multiforme (GBM) pathogenesis is largely unknown. Herein, we examine the association of PPARγ expression with its promoter and genomic global DNA methylation status, as well as DNA methyltransferases (DNMTs) gene expression in GBM patients. Methods We examined the patterns of promoter methylation and PPARγ expression in 26 GBM tissues and 13 adjacent non-tumor tissues by methylation-specific PCR (MSP), real-time PCR, and ELISA, respectively. Also, we examined the genomic global 5-methyl cytosine levels and DNMTs gene expression using ELISA and real-time PCR methods, respectively. Results We found that hypermethylation on a specific region of the PPARγ promoter is significantly associated with the downregulation of the PPARγ gene and protein level in GBM patients. Interestingly, the amount of 5-methyl cytosine level was significantly reduced in GBM patients and positively correlated with PPARγ protein expression. Furthermore, the expression level of DNMT1, DNMT3A, and 3B were upregulated in GBM patients and the average expression level of all three DNMTs was positively correlated with tumor area. Also, we found that tumors from cortical regions exhibited a higher global DNA hypomethylation and PPARγ hypermethylation was related to the increase in GBM risk. Conclusion Our study demonstrated that global DNA methylation and PPARγ epigenetic silencing is associated with the GBM risk. Our data provide a novel molecular mechanistic insight into epigenetic silencing of PPARγ in GBM patients that may be relevant as a key tumor marker for GBM pathogenesis.